LDL-Cholesterol
Showing 1 - 25 of 8,036
Hypercholesterolemia, Dyslipidemias Trial in Hamburg (lipodia)
Not yet recruiting
- Hypercholesterolemia
- Dyslipidemias
- lipodia
-
Hamburg, GermanyGAIA AG
Aug 3, 2023
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
Different Equations to Accurately Calculate LDL Cholesterol
Active, not recruiting
- Dyslipidemias
- Lipid Disorder
- no intervention, Serum LDL cholesterol calculation
-
Bron, FranceLaboratoire de Biologie Médicale Multi Sites, Centre de Biologie
Oct 24, 2022
Cardiovascular Health Trial in Alhendín (Garlic and onion concentrate, Control)
Recruiting
- Cardiovascular Health
- Garlic and onion concentrate
- Control
-
Alhendín, Granada, SpainDomca Sau
May 20, 2022
LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)
Recruiting
- LDL-cholesterol
- statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
-
Jena, Thuringia, GermanyUniversity Hospital Jena
Oct 17, 2022
Cardiovascular Disease Trial in Seoul (Intensive targeting group, Conventional therapy group)
Recruiting
- Cardiovascular Disease
- Intensive targeting group
- Conventional therapy group
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Oct 7, 2022
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
Healthy Trial in Parma (Bergamot Juice)
Recruiting
- Healthy
- Bergamot Juice
-
Parma, ItalyUniversity of Parma, Department of Medicine and Surgery
Oct 18, 2022
Categories and Attaining LDL-C Targets in Middle Eastern Adults
Not yet recruiting
- Atherosclerotic Cardiovascular Risk
- Low-density-lipoprotein (LDL) Cholesterol
- (no location specified)
Feb 16, 2023
Hypercholesterolemia Trial in Clermont-ferrand, Clermont-Ferrand, Durtol (LIMICOL, PLACEBO)
Completed
- Hypercholesterolemia
- LIMICOL
- PLACEBO
-
Clermont-ferrand, France
- +3 more
Feb 28, 2023
Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)
Active, not recruiting
- Above Optimal Plasma LDL Concentrations
- muffin
-
Winnipeg, Manitoba, Canada
- +1 more
Oct 24, 2022
Cardiovascular Diseases Trial (Meal timing)
Recruiting
- Cardiovascular Diseases
- Meal timing
-
Bath, United KingdomDepartment for Health, University of Bath
Oct 10, 2022
Hypercholesterolemia, Hyperlipidemias, Physical Inactivity Trial in Adelaide (Egg diet, Egg-free Diet, Control Diet)
Recruiting
- Hypercholesterolemia
- +3 more
- Egg diet
- +2 more
-
Adelaide, South Australia, AustraliaUniversity of South Australia Clinical Trial Facility
Mar 1, 2022
Cardiovascular Diseases, Atherosclerosis, Dyslipidemias Trial (Digitally-enabled Multifaceted Quality Improvement Intervention,
Not yet recruiting
- Cardiovascular Diseases
- +2 more
- Digitally-enabled Multifaceted Quality Improvement Intervention
- Usual care
- (no location specified)
Nov 14, 2022
To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
- Combination for Subgroup High LDL-c Patients With Other Comorbidities
- RN0191 INJECTION
- (no location specified)
Jun 14, 2023
Cholesterol Variability, Trained Immunity Trial (Atorvastatin)
Not yet recruiting
- Cholesterol Variability
- Trained Immunity
- (no location specified)
Mar 17, 2023
Hypercholesterolemia, Cardiovascular Diseases Trial in Guelph, Toronto (Canned beans of multiple varieties, White Rice)
Completed
- Hypercholesterolemia
- Cardiovascular Diseases
- Canned beans of multiple varieties
- White Rice
-
Guelph, Ontario, Canada
- +1 more
Jul 29, 2021
Hypercholesterolemia Trial (Ezetimibe, atorvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Hypercholesterolemia Trial (Ezetimibe, Simvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
LDL Cholesterol Trial in Granada (Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat)
Not yet recruiting
- LDL Cholesterol
- Cardiovascular Risk Prevention with a Mediterranean Dietary Pattern Reduced in Saturated Fat
-
Granada, SpainUniversity of Granada
Mar 9, 2023
Atherosclerosis, Cardiovascular Diseases Trial in Cambridge (Alirocumab 150 MG/ML, Ezetimibe 10Mg Tablet, Atorvastatin 40Mg
Active, not recruiting
- Atherosclerosis
- Cardiovascular Diseases
- Alirocumab 150 MG/ML
- +6 more
-
Cambridge, Cambridgeshire, United KingdomAddenbrooke's Hospital
Jul 22, 2021
Atherosclerotic Cardiovascular Disease Trial in Seoul (Ezetimibe/Statin Combination therapy, Statin monotherapy)
Recruiting
- Atherosclerotic Cardiovascular Disease
- Ezetimibe/Statin Combination therapy
- Statin monotherapy
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jun 9, 2021
Familial Hypercholesterolemia Trial in New York (Evolocumab)
Terminated
- Familial Hypercholesterolemia
-
New York, New YorkColumbia University Medical Center
Mar 5, 2021